Innovaderm Shines as Key Partner in Clinical Development and Study Management of Newly FDA-Approved Psoriasis Drug, Tapinarof
MONTREAL–(BUSINESS WIRE)–#DermatologyCRO–Innovaderm’s involvement in all phases of the clinical development of tapinarof culminated with a tremendous achievement: the recent approval of Dermavant Sciences’ VTAMA® (tapinarof) cream by the FDA for the treatment of plaque psoriasis in adults. Discovered in Canada, tapinarof is approved in the United States for the management of psoriasis, a chronic skin … [Read more…]